Kallmann R et al. |
Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects. |
1987 |
Thromb. Res. |
pmid:3576521
|
Filep J and Rosenkranz B |
Mechanism of vasopressin-induced platelet aggregation. |
1987 |
Thromb. Res. |
pmid:3105115
|
Ushiyama S et al. |
RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action. |
1988 |
Thromb. Res. |
pmid:3175990
|
Svensson J and Samuelsson K |
Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease. |
1983 |
Thromb. Res. |
pmid:20218005
|
Rogasi PG et al. |
Radioimmunoassay of thromboxane B2 in plasma: methodological modifications. |
1988 |
Thromb. Res. |
pmid:3175991
|
Takasaki W et al. |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. |
1993 |
Thromb. Res. |
pmid:8367836
|
Kosaki G et al. |
The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. |
1980 Dec 1-15 |
Thromb. Res. |
pmid:6785893
|
Butler KD et al. |
Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben. |
1987 |
Thromb. Res. |
pmid:3109067
|
Anfossi G et al. |
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. |
1995 |
Thromb. Res. |
pmid:7778055
|
Watanabe T et al. |
Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. |
2001 |
Thromb. Res. |
pmid:11672751
|
Lee GY et al. |
Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. |
2005 |
Thromb. Res. |
pmid:15668191
|
Ljungberg B et al. |
Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors. |
1988 |
Thromb. Res. |
pmid:2847353
|
Boyd JA and Eling TE |
Prostaglandin release and the interaction of platelets with the pulmonary vasculature of rat and guinea pig. |
1980 Jul 1-15 |
Thromb. Res. |
pmid:7003800
|
Pedersen AK et al. |
Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha. |
1984 |
Thromb. Res. |
pmid:6546456
|
Addonizio VP et al. |
Inhibition of human platelet function by verapamil. |
1982 |
Thromb. Res. |
pmid:7164035
|
Pekonen F et al. |
Platelet function and coagulation in normal and preeclamptic pregnancy. |
1986 |
Thromb. Res. |
pmid:2944245
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Grauso F et al. |
Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris. |
1987 |
Thromb. Res. |
pmid:2447664
|
Saldeen P et al. |
Thromboxane production in umbilical vein grafts. |
1984 |
Thromb. Res. |
pmid:6546814
|
Chou TC and Li CY |
Inhibitory mechanisms of dantrolene on platelet aggregation. |
1999 |
Thromb. Res. |
pmid:10593433
|
Davì G et al. |
Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. |
1982 |
Thromb. Res. |
pmid:6761893
|
Rousson D et al. |
Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. |
1987 |
Thromb. Res. |
pmid:3122356
|
Navran SS et al. |
Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. |
1984 |
Thromb. Res. |
pmid:6372157
|
Vanags D et al. |
The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. |
1990 |
Thromb. Res. |
pmid:2264023
|
Cerskus AL et al. |
Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone. |
1980 |
Thromb. Res. |
pmid:7414555
|
Castaldi PA et al. |
Evidence for a platelet membrane defect in the myeloproliferative syndromes. |
1982 |
Thromb. Res. |
pmid:6960545
|
Kankuri E et al. |
Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. |
2003 |
Thromb. Res. |
pmid:14592552
|
Davis RB et al. |
Evaluation of platelet function in pregnancy. Comparative studies in non-smokers and smokers. |
1987 |
Thromb. Res. |
pmid:2955542
|
Di Minno G et al. |
Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides. |
1982 |
Thromb. Res. |
pmid:6803385
|
Catella F and FitzGerald GA |
Paired analysis of urinary thromboxane B2 metabolites in humans. |
1987 |
Thromb. Res. |
pmid:3686481
|
Suehiro A et al. |
The role of platelet hyperfunction in thrombus formation in hyperlipidemia. |
1982 |
Thromb. Res. |
pmid:6803387
|
Vericel E et al. |
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. |
1988 |
Thromb. Res. |
pmid:3129819
|
Arruzazabala ML et al. |
Effects of Policosanol on platelet aggregation in rats. |
1993 |
Thromb. Res. |
pmid:8475481
|
Reis F et al. |
The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. |
1999 |
Thromb. Res. |
pmid:10605951
|
Riess H et al. |
Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease. |
1984 |
Thromb. Res. |
pmid:6237460
|
Cattaneo M et al. |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. |
1991 |
Thromb. Res. |
pmid:1926062
|
Weide I et al. |
Effects of cyclooxygenase inhibitors on ex vivo cysteinyl-leukotriene production by whole human blood allowed to clot spontaneously. Comparison to stimulated blood. |
1992 |
Thromb. Res. |
pmid:1440511
|
Udvardy M et al. |
Alterations of primary haemostasis in mixed connective tissue disease (MCTD). |
1991 |
Thromb. Res. |
pmid:1835548
|
Patrono C et al. |
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368167
|
Koh H et al. |
A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368170
|
Tindall H et al. |
Thrombin generation precedes platelet activation in native blood taken from the hand during multiple blood sampling following cold challenge. |
1987 |
Thromb. Res. |
pmid:3617016
|
Kohda N et al. |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. |
1999 |
Thromb. Res. |
pmid:10593428
|
Deckmyn H et al. |
Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. |
1983 |
Thromb. Res. |
pmid:6344317
|
Winther K et al. |
Platelet function and fibrinolytic activity in cervical spinal cord injured patients. |
1992 |
Thromb. Res. |
pmid:1321515
|
Chetty N and Bradlow BA |
The effects of a vegetarian diet on platelet function and fatty acids. |
1983 |
Thromb. Res. |
pmid:6612688
|
Vesterqvist O et al. |
Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. |
1984 |
Thromb. Res. |
pmid:6695361
|
Lee TK et al. |
Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke. |
1987 |
Thromb. Res. |
pmid:3629557
|
Tanoue K et al. |
A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa. |
1987 |
Thromb. Res. |
pmid:3629560
|
Altman R and Scazziota A |
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. |
1986 |
Thromb. Res. |
pmid:3088757
|
Franconi F et al. |
Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. |
2001 |
Thromb. Res. |
pmid:11369419
|
Petroni A et al. |
Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. |
1995 |
Thromb. Res. |
pmid:7482432
|
De La Cruz JP et al. |
Antithrombotic potential of olive oil administration in rabbits with elevated cholesterol. |
2000 |
Thromb. Res. |
pmid:11113274
|
Barnhart MI et al. |
DDAVP: does the drug have a direct effect on the vessel wall? |
1983 |
Thromb. Res. |
pmid:6415852
|
Todd MK et al. |
Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2, and 6-keto-PGF1 alpha/TXB2 ratios. |
1992 |
Thromb. Res. |
pmid:1615492
|
Davì G et al. |
Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs. |
1985 |
Thromb. Res. |
pmid:2933846
|
Dembinska-Kiec A et al. |
Ticlopidine and platelet function in healthy volunteers. |
1992 |
Thromb. Res. |
pmid:1615496
|
Saldeen P and Saldeen T |
6-keto-prostaglandin F1 alpha/thromboxane B2 ratio in vascular and lung tissue. |
1983 |
Thromb. Res. |
pmid:6688484
|
Sandler H et al. |
Studies on the role of thromboxane in thrombin-induced pulmonary insufficiency in the rat. |
1986 |
Thromb. Res. |
pmid:3754987
|
Pattison A et al. |
The in vitro effect of amrinone on thromboxane B2 synthesis in human whole blood. |
1986 |
Thromb. Res. |
pmid:3755259
|
Maguire ED and Wallis RB |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. |
1983 |
Thromb. Res. |
pmid:6689221
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Lagarde M et al. |
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. |
1980 |
Thromb. Res. |
pmid:7466751
|
Ames PR et al. |
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. |
2012 |
Thromb. Res. |
pmid:22521214
|
McGill D et al. |
Platelet function and exercise-induced myocardial ischaemia in coronary heart disease patients. |
1989 |
Thromb. Res. |
pmid:2533414
|
Li C et al. |
Aspirin response variability after major orthopedic surgery. |
2012 |
Thromb. Res. |
pmid:22575418
|
Weide I et al. |
Intravascular cysteinyl-leukotriene formation by clotting whole human blood. Evidence from clamped umbilical vein segments and thrombus specimens. |
1993 |
Thromb. Res. |
pmid:8122190
|
Uyama O et al. |
Plasma concentrations of 6-keto-prostaglandin F1 alpha in patients with hypertension, cerebrovascular disease or Takayasu's arteritis. |
1982 Jan 1-15 |
Thromb. Res. |
pmid:6121391
|
Voss R et al. |
In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy. |
1993 |
Thromb. Res. |
pmid:8122187
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Takasaki W et al. |
Enzyme immunoassay of human plasma 11-dehydrothromboxane B2. |
1991 |
Thromb. Res. |
pmid:1957275
|
Hofmann D et al. |
Evidence for sustained platelet activation in patients with early postinfarction angina. |
1993 |
Thromb. Res. |
pmid:8303651
|
Toft G et al. |
Intravenously and topically applied magnesium in the prevention of arterial thrombosis. |
2000 |
Thromb. Res. |
pmid:10904104
|
Korth R et al. |
Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes. |
1986 |
Thromb. Res. |
pmid:3961742
|
Schmid P et al. |
Passive smoking and platelet thromboxane. |
1996 |
Thromb. Res. |
pmid:8907294
|
Sinzinger H et al. |
Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteers. |
1989 |
Thromb. Res. |
pmid:2497545
|
Riess H et al. |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients. |
1986 |
Thromb. Res. |
pmid:3012819
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
Altman R et al. |
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma. |
1986 |
Thromb. Res. |
pmid:3014677
|
Teng CM et al. |
Platelet aggregation induced by equinatoxin. |
1988 |
Thromb. Res. |
pmid:2906181
|
Selley ML et al. |
The effect of cholesterol oxidation products on human platelet aggregation. |
1996 |
Thromb. Res. |
pmid:8885139
|
De Caterina R et al. |
Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina. |
1990 |
Thromb. Res. |
pmid:2126400
|
Yamaguchi A et al. |
Effect of cetiedil on platelet aggregation and thromboxane synthesis. |
1985 |
Thromb. Res. |
pmid:2986312
|
Lai LJ et al. |
Trilinolein inhibits epinephrine-induced human platelet aggregation. |
1994 |
Thromb. Res. |
pmid:7863478
|
Wu TM et al. |
Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation. |
2000 |
Thromb. Res. |
pmid:10674405
|
Ding YA et al. |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound. |
1995 |
Thromb. Res. |
pmid:7740521
|
Leoncini G et al. |
In retinal vein occlusion platelet response to thrombin is increased. |
2009 |
Thromb. Res. |
pmid:19660790
|
Perneby C et al. |
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. |
1999 |
Thromb. Res. |
pmid:10632465
|
Prosdocimi M et al. |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. |
1985 |
Thromb. Res. |
pmid:3840290
|
Schorer AE and White JG |
Interleukin 1 enhances arterial thrombogenicity in vitro. |
1989 |
Thromb. Res. |
pmid:2609290
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Udvardy M et al. |
Altered primary haemostasis in Conn's syndrome. |
1992 |
Thromb. Res. |
pmid:1448795
|
Simmet T and Weide I |
Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. |
1991 |
Thromb. Res. |
pmid:1866709
|
De la Cruz JP et al. |
Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. |
1997 |
Thromb. Res. |
pmid:9219331
|
Lukaszyk A et al. |
Does acute experimental pancreatitis affect blood platelet function? |
1989 |
Thromb. Res. |
pmid:2524119
|
Delvos U et al. |
Direct radioimmunological measurement of thromboxane B2 in plasma. |
1985 |
Thromb. Res. |
pmid:4082109
|
Swart SS et al. |
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. |
1984 |
Thromb. Res. |
pmid:6326344
|
Ito T et al. |
Role of activated platelets in endotoxin-induced DIC in rats. |
1990 |
Thromb. Res. |
pmid:2080492
|
Alessandrini P et al. |
Physiologic variables affecting thromboxane B2 production in human whole blood. |
1985 |
Thromb. Res. |
pmid:3983893
|
Barbieri B et al. |
p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner. |
1997 |
Thromb. Res. |
pmid:9175234
|